GRTS News and Press, Gritstone Oncology Inc. From 07/26/22

EMERYVILLE, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the company’s Board of Directors has granted three employees nonqualifie...

Gritstone bio ( NASDAQ: GRTS ) on Thursday announced an $80M credit facility with Hercules Capital ( HTGC ) and Silicon Valley Bank. At closing, $20M was drawn with an additional $10M available for drawdown by Mar. 15, 2023. The remaining $50M will be available in ...

EMERYVILLE, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, announced that it will host a conference call and webcast at 4:30pm ET on Thursday, August 4, 2022, to...

EMERYVILLE, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced it has entered into an $80 million credit facility with Hercules Capital, Inc. (NYSE...

Gritstone has a proprietary vaccine development platform that discovers neoantigens against viruses and cancer cells. A recent spike after a SARS-CoV-2 vaccine announcement has placed a premium on the stock price. I believe their COVID and cancer vaccine programs will have signifi...

Alithya Group (ALYA) +237%.Avino Silver & Gold Mines (ASM) +132%.Comstock Mining (LODE) +73%.Viela Bio (VIE) +53%.Phunware (PHUN) +50%.Tuscan Holdings Corp. (THCB) +45% as Microvast go public through a merger with the company.First Majestic Silver (AG) +37%.Borqs Technologies (BRQS) ...

Gilead Sciences (GILD) and Gritstone Oncology (GRTS), up 44% premarket have entered into a collaboration, option and license agreement to research and develop a vaccine-based immunotherapy to find a curative treatment for HIV infection. Under the terms of agreement, Gilead will make...

Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced that the companies have entered into a collaboration, option and license agr...

Gritstone Oncology (GRTS) files for a mixed shelf offering of up to $690M.The filing does not necessarily indicate that a sale has begun, or will occur in the future.SEC Form S-3Shares are unchanged in after-hours trading.Shares closed up 5.5% to $18.11. For further details see: ...

Gainers: Oxbridge Re (OXBR) +62%.Koss (KOSS) +60%.AIkido Pharma (AIKI) +51%.Vertex Energy (VTNR) +56%.Phunware (PHUN) +45%.Edesa Biotech (EDSA) +33%.CarParts.com (PRTS) +32%.Workhorse Group (WKHS) +30%.Orbital Energy (OEG) +27%.Vir Biotechnology (VIR) +27%.Losers: Express ...